Latest Content

The FDA has accepted a sNDA for Ameluz topical gel, used in combination with the RhodoLED red-light lamp series, for superficial basal cell carcinoma treatment.

The U.S. Food and Drug Administration has approved a new treatment for adults with locally advanced pancreatic cancer.

Colleen Mabasa reflected on the importance of self-advocacy, as well as seeking second opinions and ensuring patients understand all available options.

Riozzi Bodine shares how her daughter’s diagnosis inspired the launch of a foundation offering cold caps, wigs and caregiver support.

A nurse practitioner explains how FDA approval of subcutaneous Rybrevant may reduce treatment burden and improve care for patients with EGFR-mutated lung cancer.

New research shows specific chemotherapies and radiation increase the risk of subsequent brain tumors in long-term childhood cancer survivors.

Showing up taking notes and learning the disease can help families feel empowered as new treatments expand hope and quality of life.

Laura Yeager reflects on losses from theft and cancer, showing how resilience grows and gratitude emerges even after life's hardest setbacks.

CURE spoke with a provider and a survivor about the potential power of minimal residual disease testing.

The FDA approved protocol updates to a tasquinimod trial in myelofibrosis, allowing broader enrollment and combination use with JAK inhibitors.

In an interview, liver cancer survivor Charles Walker shared how family support and a living donor transplant changed his treatment journey and outlook.

The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for autologous stem cell transplant.

FDA OKs Keytruda with paclitaxel for PD-L1 positive, platinum-resistant ovarian, fallopian tube or peritoneal cancers, improving survival and delaying growth.